DNMT3A and colorectal carcinoma: In a study on the molecular mechanism of thymine-DNA glycosylase (TDG) treatment for CRC, Miao et al. (2022) found that TDG could bind to and promote the ubiquitination and degradation of DNMT3A, by inhibiting CRC migration and invasion.